The New Normal Fund

The New Normal Fund is a venture capital firm based in San Francisco, California, focusing on early-stage investments in technology companies. The firm specializes in sectors such as fintech, artificial intelligence, health tech, blockchain, and Web3, aiming to support startups that are adapting to changing market conditions and societal shifts. Their investment strategy emphasizes providing capital and strategic guidance to help these companies navigate evolving trends.

The fund primarily invests in seed and Series A stages, with typical investment sizes ranging from $500,000 to $5 million. Their geographical focus is on the United States, reflecting a commitment to fostering innovation within the country. The New Normal Fund's approach combines financial support with operational expertise, assisting portfolio companies in scaling their operations and achieving sustainable growth.

With a robust background in venture capital, the fund manager has successfully completed over 50 deals across technology and healthcare sectors, primarily in North America and Europe. Emphasizing a data-driven investment strategy, they have navigated various stages of investment, from seed to growth equity. Their approach prioritizes operator-first insights, leading to notable exits that include several high-profile IPOs and acquisitions. This seasoned professional combines analytical rigor with a keen understanding of market trends to identify transformative opportunities.